- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Horizon Pharma, Inc.
Total 2542 results
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedJuvenile Idiopathic Arthritis (JIA)United States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States, Canada
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedRheumatoid ArthritisUnited States, Germany, Hungary, Canada, Poland, United Kingdom
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedOsteoarthritis | Rheumatoid Arthritis | Chronic Low Back Pain | Chronic Regional Pain Syndrome | Chronic Soft Tissue PainUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States, Canada
-
Horizon Pharma Ireland, Ltd., Dublin IrelandTerminatedHepatic EncephalopathyUnited States
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted
-
Sawa Ito, MDHorizon Pharma USA, Inc.CompletedMyelodysplastic Syndromes | Myeloid Leukemia | Allogeneic Stem Cell TransplantationUnited States
-
Orion Corporation, Orion PharmaRecruiting
-
Orion Corporation, Orion PharmaCompletedChronic Low Back PainFinland
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedAlzheimer's DiseaseFinland
-
Orion Corporation, Orion PharmaCompletedChronic Obstructive Pulmonary Disease | AsthmaGermany
-
Orion Corporation, Orion PharmaCompletedProstate CancerFinland, France, United Kingdom, Latvia
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedHealthy Volunteer StudyFinland
-
Orion Corporation, Orion PharmaTerminated
-
Orion Corporation, Orion PharmaCompletedICU SedationRussian Federation
-
Orion Corporation, Orion PharmaCompletedHealthy SubjectsFinland
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedSafety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers (FIMPAM)Healthy Volunteer StudyGermany
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaTerminatedRaynaud's PhenomenonUnited Kingdom
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedContinuous Sedation in Initially Sedated Adults in ICUNetherlands, Belgium, Estonia, Finland, France, Germany, Norway, Switzerland, United Kingdom
-
Orion Corporation, Orion PharmaCompletedChronic Obstructive Pulmonary Disease | AsthmaFinland, Estonia
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited Kingdom, Finland
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedStroke | Transient Ischemic AttackFinland, Germany, Hungary, Sweden
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedIdiopathic Parkinson's DiseaseUnited Kingdom, Denmark, Ireland, Finland, Germany, Sweden
-
Orion Corporation, Orion PharmaCompletedHealthy Male VolunteersNetherlands
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompletedCoronary Heart DiseaseFinland
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States